Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 12

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 12
---
. 1 — The Business Combination Proposal —to consider and vote upon a proposal to approve (i) the Business Combination (as defined herein), (ii) the adoption of the Agreement and Plan of Merger, dated as of September 16, 2024 (the “Merger Agreement”), by and among FutureTech, Longevity Biomedical, Inc., a Delaware corporation (“Longevity”), LBI Merger Sub, Inc., a Delaware corporation and direct, wholly-owned subsidiary of FutureTech (“Merger Sub”), and Bradford A. Zakes, solely in the capacity as seller representative, and (iii) the transactions contemplated by the Merger Agreement, as more fully described elsewhere in the accompanying proxy statement/prospectus;

Proposal No. 2 — The Charter Approval Proposal —To consider and vote upon a proposal to adopt the Second Amended and Restated Certificate of Incorporation in the form attached hereto as Annex B;

Proposal No. 3 — The Governance Proposals —To consider and vote upon, on a non-binding advisory basis, separately presented proposals with respect to certain governance provisions in the Second Amended and Restated Certificate of Incorporation in accordance with SEC requirements;

Proposal No. 4— The Director Election Proposal—To consider and vote upon a proposal to elect seven directors to our board of directors (our “Board”) to serve as our directors for a term of three years expiring at the annual meeting of stockholders to be held in 2028 or until each such director’s successor has been duly elected and qualified, or until each such director’s earlier death, resignation, retirement or removal;

Proposal No. 5 — The Incentive Plan Proposal —to consider and vote upon a proposal to approve and assume the Longevity Biomedical, Inc. 2025 Equity Incentive Plan (the “Equity Incentive Plan”) and any grants or awards issued thereunder; and

Proposal No. 6 — The Adjournment Proposal —to consider and vote upon a proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient shares represented to constitute a quorum necessary to conduct business at the Special Meeting or for the approval of one or more proposals at the Special Meeting or to the extent necessary to ensure that any required supplement or amendment to the accompanying proxy statement/prospectus is provided to FutureTech stockholders.

Each of Proposals No. 1, 2,